You are here » Home » Markets » Stocks » Announcements

ANNOUNCEMENTS

Announcement for "Aurobindo Pharma Ltd"

Aurobindo Pharma Ltd Compliances-Reg.24(A)-Annual Secretarial Compliance

  • 16/05/2022
  • |
  • bse

Aurobindo Pharma Ltd Completion Of US FDA Inspection At Our Unit VII - Reg.

  • 10/05/2022
  • |
  • bse

Aurobindo Pharma Ltd Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.

  • 10/05/2022
  • |
  • bse

Aurobindo Pharma Ltd Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure

  • 06/05/2022
  • |
  • bse

Aurobindo Pharma Ltd Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)

  • 03/05/2022
  • |
  • bse

Aurobindo Pharma Ltd Compliance Certificate Under Regulation 40(9) For The Year Ended 31.03.2022.

  • 27/04/2022
  • |
  • bse

Aurobindo Pharma Ltd Statement Of Investor Complaints For The Quarter Ended March 2022

  • 19/04/2022
  • |
  • bse

  • 13/04/2022
  • |
  • bse

Aurobindo Pharma Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

  • 13/04/2022
  • |
  • bse

Aurobindo Pharma Ltd Closure of Trading Window

  • 29/03/2022
  • |
  • bse

Aurobindo Pharma Ltd Announcement under Regulation 30 (LODR)-Acquisition

  • 28/03/2022
  • |
  • bse

Aurobindo Pharma Ltd Announcement under Regulation 30 (LODR)-Newspaper Publication

  • 25/03/2022
  • |
  • bse

Aurobindo Pharma Ltd Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

  • 21/03/2022
  • |
  • bse

Aurobindo Pharma Ltd Announcement under Regulation 30 (LODR)-Press Release / Media Release

  • 17/03/2022
  • |
  • bse

Aurobindo Pharma Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

  • 11/03/2022
  • |
  • bse

Aurobindo Pharma Ltd Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

  • 04/03/2022
  • |
  • bse

Aurobindo Pharma Ltd Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

  • 23/02/2022
  • |
  • bse

Aurobindo Pharma Ltd Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.

  • 22/02/2022
  • |
  • bse

Aurobindo Pharma Ltd Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.

  • 22/02/2022
  • |
  • bse

Aurobindo Pharma Ltd Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.

  • 18/02/2022
  • |
  • bse
.